FDA.reportPublic FDA data

BRAFTOVI 75 MG Oral Capsule

RxCUI
2049121
RxNorm name
BRAFTOVI 75 MG Oral Capsule
Display name
BRAFTOVI 75 MG Oral Capsule
Full name
BRAFTOVI 75 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BRAFTOVIENCORAFENIBArray BioPharma Inc.235dfc38-0f0b-4037-b501-7a9f4294740c2026-02-26Warnings, Adverse reactionsExact identifier
rxcui: 2049121

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
235dfc38-0f0b-4037-b501-7a9f4294740cBRAFTOVI 75 MG Oral Capsule [PSN] · encorafenib 75 MG Oral Capsule [Braftovi] [SBD] · Braftovi 75 MG Oral Capsule [SY]323These highlights do not include all the information needed to use BRAFTOVI safely and effectively. See full prescribing information for BRAFTOVI. BRAFTOVI ® (encorafenib) capsules, for oral use Initial U.S. Approval: 201820260226